These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9313951)

  • 61. Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields.
    Varani K; De Mattei M; Vincenzi F; Gessi S; Merighi S; Pellati A; Ongaro A; Caruso A; Cadossi R; Borea PA
    Osteoarthritis Cartilage; 2008 Mar; 16(3):292-304. PubMed ID: 17698373
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Use of the triazolotriazine [3H]ZM 241385 as a radioligand at recombinant human A2B adenosine receptors.
    Ji XD; Jacobson KA
    Drug Des Discov; 1999 Nov; 16(3):217-26. PubMed ID: 10624567
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects.
    Varani K; Portaluppi F; Gessi S; Merighi S; Ongini E; Belardinelli L; Borea PA
    Circulation; 2000 Jul; 102(3):285-9. PubMed ID: 10899090
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors.
    Ongini E; Dionisotti S; Gessi S; Irenius E; Fredholm BB
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):7-10. PubMed ID: 9933143
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors.
    Varani K; Surprenant A; Vincenzi F; Tosi A; Gessi S; Merighi S; Borea PA
    Biochem Pharmacol; 2008 Mar; 75(5):1198-208. PubMed ID: 18076867
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Selective adenosine A2A receptor antagonists.
    Ongini E; Monopoli A; Cacciari B; Baraldi PG
    Farmaco; 2001; 56(1-2):87-90. PubMed ID: 11347973
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A(3) adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study.
    Gessi S; Varani K; Merighi S; Cattabriga E; Iannotta V; Leung E; Baraldi PG; Borea PA
    Mol Pharmacol; 2002 Feb; 61(2):415-24. PubMed ID: 11809867
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Novel 8-(furan-2-yl)-3-substituted thiazolo [5,4-e][1,2,4] triazolo[1,5-c] pyrimidine-2(3H)-thione derivatives as potential adenosine A(2A) receptor antagonists.
    Mishra CB; Barodia SK; Prakash A; Senthil Kumar JB; Luthra PM
    Bioorg Med Chem; 2010 Apr; 18(7):2491-500. PubMed ID: 20303771
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Experimental hypothyroidism modifies specific binding of A1 and A2A analogues to adenosine receptors in the rat kidney.
    Franco M; Galicia O; Quintana A; Martínez F
    Br J Pharmacol; 2004 Jun; 142(3):461-8. PubMed ID: 15148254
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 8-(Furan-2-yl)-3-phenethylthiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2(3H)-thione as novel, selective and potent adenosine A(2A) receptor antagonist.
    Kumari N; Mishra CB; Prakash A; Kumar N; Mongre R; Luthra PM
    Neurosci Lett; 2014 Jan; 558():203-7. PubMed ID: 24161891
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A(1) adenosine receptor ligands.
    Giovannoni MP; Vergelli C; Cilibrizzi A; Crocetti L; Biancalani C; Graziano A; Dal Piaz V; Loza MI; Cadavid MI; Díaz JL; Gavaldà A
    Bioorg Med Chem; 2010 Nov; 18(22):7890-9. PubMed ID: 20937560
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats.
    Corsi C; Pinna A; Gianfriddo M; Melani A; Morelli M; Pedata F
    Eur J Pharmacol; 2003 Mar; 464(1):33-8. PubMed ID: 12600692
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5-c]pyrimidines to explore the antagonist profiling on adenosine receptors: a preliminary structure-activity relationship study.
    Federico S; Ciancetta A; Porta N; Redenti S; Pastorin G; Cacciari B; Klotz KN; Moro S; Spalluto G
    J Med Chem; 2014 Jul; 57(14):6210-25. PubMed ID: 24972108
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Binding affinity of adenosine receptor agonists and antagonists at human cloned A3 adenosine receptors.
    Varani K; Cacciari B; Baraldi PG; Dionisotti S; Ongini E; Borea PA
    Life Sci; 1998; 63(5):PL 81-7. PubMed ID: 9714428
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacological characterization of the rat A2a adenosine receptor functionally coupled to the yeast pheromone response pathway.
    Price LA; Strnad J; Pausch MH; Hadcock JR
    Mol Pharmacol; 1996 Oct; 50(4):829-37. PubMed ID: 8863827
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 4-Amino-6-benzylamino-1,2-dihydro-2-phenyl-1,2,4-triazolo [4,3-alpha]-quinoxalin-1-one: a new A2A adenosine receptor antagonist with high selectivity versus A1 receptors.
    Colotta V; Catarzi D; Varano F; Cecchi L; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
    Arch Pharm (Weinheim); 1999 Feb; 332(2):39-41. PubMed ID: 10233008
    [No Abstract]   [Full Text] [Related]  

  • 77. Synthesis and biological study of 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines as potent and selective serotonin 5-HT6 receptor antagonists.
    Ivachtchenko AV; Golovina ES; Kadieva MG; Koryakova AG; Kovalenko SM; Mitkin OD; Okun IM; Ravnyeyko IM; Tkachenko SE; Zaremba OV
    Bioorg Med Chem; 2010 Jul; 18(14):5282-90. PubMed ID: 20541425
    [TBL] [Abstract][Full Text] [Related]  

  • 78. QSAR of adenosine receptor antagonists: Exploring physicochemical requirements for binding of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives with human adenosine A(3) receptor subtype.
    Pran Kishore D; Balakumar C; Raghuram Rao A; Roy PP; Roy K
    Bioorg Med Chem Lett; 2011 Jan; 21(2):818-23. PubMed ID: 21163647
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension.
    Varani K; Manfredini R; Iannotta V; Pancaldi C; Cattabriga E; Uluoglu C; Borea PA; Portaluppi F
    Hypertension; 2002 Dec; 40(6):909-13. PubMed ID: 12468578
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Potent and selective adenosine A2A receptor antagonists: 1,2,4-Triazolo[1,5-c]pyrimidines.
    Neustadt BR; Liu H; Hao J; Greenlee WJ; Stamford AW; Foster C; Arik L; Lachowicz J; Zhang H; Bertorelli R; Fredduzzi S; Varty G; Cohen-Williams M; Ng K
    Bioorg Med Chem Lett; 2009 Feb; 19(3):967-71. PubMed ID: 19109019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.